Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)

Please use this identifier to cite or link to this item: https://doi.org/10.1097/JTO.0b013e3181913e28

Title:	Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC)
Authors:	Lim, E.H. Chang, A. Tan, P. Zhang, S.-L. Li, J.-L. Yap, W.-S. Ng, A. Howe, T.-C. Tan, B.-P. Lee, Y.-S. Wong, D. Khoo, K.-L. Seto, K.-Y. Tan, L. Agasthian, T. Koong, H.-N. Tam, J. Tan, C. Caleb, M.
Keywords:	Advanced stage CMET mutations Early stage EGFR mutations KRAS mutations Low-volume biopsies Non-small cell lung cancer P53 mutations Prognosis Whole genome amplification
Issue Date:	2009
Citation:	Lim, E.H., Chang, A., Tan, P., Zhang, S.-L., Li, J.-L., Yap, W.-S., Ng, A., Howe, T.-C., Tan, B.-P., Lee, Y.-S., Wong, D., Khoo, K.-L., Seto, K.-Y., Tan, L., Agasthian, T., Koong, H.-N., Tam, J., Tan, C., Caleb, M. (2009). Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology 4 (1) : 12-21. ScholarBank@NUS Repository. https://doi.org/10.1097/JTO.0b013e3181913e28
Source Title:	Journal of Thoracic Oncology
URI:	http://scholarbank.nus.edu.sg/handle/10635/24184
ISSN:	15560864 15561380
DOI:	10.1097/JTO.0b013e3181913e28
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check